Look for:

Products

ASTRAZENECA PLC


ISIN:
GB0009895292
WKN:
0989529

2022/09/23 17:29:35
Price
1,237.50 SEK
Difference -0.56% (-7.00)

General attributes

ISINGB0009895292
SymbolAZN
ExchangeNasdaq Stockholm
CurrencySEK
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)177,655 EUR
BenchmarkFTSE 100

Market data

Bid (Bid size)1,239.00 SEK (35)
Ask (Ask size)1,240.00 SEK (1,562)
Open1,252.00 SEK
High1,256.00 SEK
Low1,217.00 SEK
Close (prev. day)1,244.50 SEK
VWAP1,234.268548 SEK
Volume (pcs)441,794
Trading volume545,260,468.00
Number of trades5,127
Last size221

Futures and Options

Related Futures48
Related Options-
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research

Date Headline Download
2022/09/01 en Global Equity Ratings PDF Download
2022/08/25 en Global Equity Ratings PDF Download
2022/08/18 en Global Equity Ratings PDF Download
2022/08/08 en Global Equity Ratings PDF Download
2022/07/25 en Global Equity Ratings PDF Download


2022/09/23 17:29:35
Price
1,237.50 SEK
Difference -0.56% (-7.00)

General attributes

ISINGB0009895292
SymbolAZN
ExchangeNasdaq Stockholm
CurrencySEK
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)177,655 EUR
BenchmarkFTSE 100

Market data

Bid (Bid size)1,239.00 SEK (35)
Ask (Ask size)1,240.00 SEK (1,562)
Open1,252.00 SEK
High1,256.00 SEK
Low1,217.00 SEK
Close (prev. day)1,244.50 SEK
VWAP1,234.268548 SEK
Volume (pcs)441,794
Trading volume545,260,468.00
Number of trades5,127
Last size221

Performance and Risk

6m1Y3Y
Perf (%)+2.12%+20.38%+42.13%
Perf (abs.)+25.70+209.50+366.80
Beta0.750.850.59
Volatility23.2525.4526.62
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)1,248.30 SEK (385,740)
Ø price 30 days | Ø volume 30 days (pcs.)1,331.42 SEK (399,894)
Ø price 100 days | Ø volume 100 days (pcs.)1,321.51 SEK (420,473)
Ø price 250 days | Ø volume 250 days (pcs.)1,194.78 SEK (469,522)
YTD High | date1,456.50 SEK (2022/08/22)
YTD Low | date1,018.60 SEK (2022/02/07)
52 Weeks High | date1,456.50 SEK (2022/08/22)
52 Weeks Low | date978.10 SEK (2021/12/13)

Arbitrage views

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Berlin2022/09/2308:08114.10 EUR0.001
Duesseldorf2022/09/2321:01112.45 EUR0.0011
FINRA other OTC Issues2022/09/2321:02108.35 USD0.9167
Frankfurt2022/09/2316:04113.00 EUR0.024
Hamburg2022/09/2308:01113.65 EUR0.001
Hanover2022/09/2308:01113.65 EUR0.001
London Stock Exchange2022/09/2317:3510,016.00 GBp16,364.6819,833
Munich2022/09/2308:00113.90 EUR0.001
Nasdaq Stockholm2022/09/2317:291,237.50 SEK545.265,127
SIX Swiss Exchange2022/04/1417:3595.03 CHF0.001
Stuttgart2022/09/2316:41113.05 EUR0.028
Tradegate2022/09/2322:26112.875 EUR0.9176
Xetra2022/09/2317:35113.00 EUR4.76205

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=475&ID_TYPE_IMAGE_LOGO=2

Contact Details

ASTRAZENECA PLC
- -
Cambridge Biomedical Campus - CB2 0AA Cambridge
Telefon: 44-20-3749-5000
Fax: 44-12-2335-2858
E-mail: -

PDF Downloads

Company report: ASTRAZENECA PLCPDF Download

Company Profile

AstraZeneca Plc is a holding company, which engages in the research, development, and manufacture of pharmaceutical products. It focuses on the discovery, development, and commercialization of prescription medicines in Oncology and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. These pharmaceutical products are then manufactured, marketed and sold. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.

Board of directors

Leif Valdemar JohanssonChairman of Supervisory Board
Andreas RummeltMember of Supervisory Board
Aradhana SarinMember of Supervisory Board
Euan AshleyMember of Supervisory Board
Nazneen RahmanMember of Supervisory Board
Tony MokMember of Supervisory Board
Deborah DiSanzoMember of Supervisory Board
Diana LayfieldMember of Supervisory Board
Marcus WallenbergMember of Supervisory Board
Michel DemaréMember of Supervisory Board
Philip BroadleyMember of Supervisory Board
Sherilyn McCoyMember of Supervisory Board





Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR CORPORATE AND INSTITUTIONAL CLIENTS

Any information, material and services regarding financial instruments and securities provided by Erste Group Bank AG or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites”) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions (the “Interested Party“).

The publication and distribution of information as well as offering and selling of products and services described on the Websites is prohibited by law in some jurisdictions. For this reason, persons in countries in which the publication as well as the offering and selling of products and services described on the Websites are not permitted by law, must not enter the Websites and/or acquire the products displayed on the Websites.

Neither Erste Group nor any third party shall offer access to the Websites or offer the products to especially, but not limited to citizen/residents of the United States and “U.S. person” (as defined in Regulation S under the US Securities Act 1933 as amended), citizen/resident of Australia, Canada, Great Britain and Japan. For this reason, the distribution or redistribution of the information, materials and products into United States, Australia, Canada, Great Britain and Japan or into any other jurisdiction where it is not permitted under the applicable law, as well as to the citizens/residents of these countries shall be prohibited.

The securities displayed on the Websites have not been and will not be registered under the US Securities Act of 1933 and trading in the securities has not been approved for purposes of the US Commodities Exchange Act of 1936. For this reason the securities may, inter alia, not be offered, sold or delivered within the United States or, for the account and benefit of U.S. persons.

The Interested Party is solely responsible to examine, whether he may enter the Websites under the law applicable to it. Erste Group shall not be responsible for the distribution of content of any of the Websites to individuals or entities which provide false information about their right to enter the Websites. For this reason Erste Group shall not be liable for any legal claims or damages which may result from the unauthorized entering or reading of the Websites.

By agreeing to this hereto, the Interested Party confirms that
(i) It has read, understood and accepted this Information and the Disclaimer;
(ii) It informed itself about any possible legal restriction and warrants that it is not restricted or prohibited to enter the Websites according to any law applicable; and
(iii) It does not make available the contents of the Websites to any person who is not qualified by law to enter the Websites.
(iV) It is no consumer.